Robert D. Hubbard - Concepedia

Author

Robert D. Hubbard

Abbott Fund

Also Known As

Hubbard, R.D., R. D. HUBBARD, R.D. Hubbard, Robert D Hubbard, Robert D. Hubbard, Robert Hubbard, Robert D. Hubbard

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Abbott Fund Stanford University Abbott (United States)Research Triangle Park Foundation GlaxoSmithKline (United States)

About

Robert D. Hubbard is an author at Abbott Fund specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	351
2	Natural Sciences	9	9	483
3	Biochemistry	9	9	483
4	Engineering	5	5	502
5	Biomolecular Engineering	2	2	89

Robert D. Hubbard

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Three-Component Cycloadditions: The First Transition Metal-Catalyzed [5+2+1] Cycloaddition Reactions Paul A. Wender, Gabriel G. Gamber, Robert D. Hubbard, Journal of the American Chemical Society Building BlocksChemical EngineeringThird ComponentEngineeringHeterocyclic	2002	171
Multicomponent Cycloadditions: The Four-Component [5+1+2+1] Cycloaddition of Vinylcyclopropanes, Alkynes, and CO Paul A. Wender, Gabriel G. Gamber, Robert D. Hubbard, Journal of the American Chemical Society Terminal AlkynesMedicinal ChemistryCross-coupling ReactionEngineeringHeterocyclic	2005	151
Toward the ideal synthesis. New transition metal-catalyzed reactions inspired by novel medicinal leads Paul A. Wender, F. Christopher Bi, Gabriel G. Gamber, Pure and Applied Chemistry Medicinal ChemistryChemical EngineeringEngineeringAlkene MetathesisBiochemistry	2002	129
Total Synthesis of (−)-Laulimalide Paul A. Wender, Sayee G. Hegde, Robert D. Hubbard, Journal of the American Chemical Society	2002	94
Microtubule-stabilizing agents based on designed laulimalide analogues Susan L. Mooberry, Deborah A. Randall‐Hlubek, Rachel M. Leal, Proceedings of the National Academy of Sciences	2004	69
Highly Substituted <i>t</i><i>er</i>-Cyclopentanes as Receptors for Lipid A Robert D. Hubbard, Scott R. Horner, Benjamin L. Miller Journal of the American Chemical Society Molecular PharmacologyPharmaceutical ScienceBiochemistryDonut IconMedicine	2001	68
Fragment-Based, Structure-Enabled Discovery of Novel Pyridones and Pyridone Macrocycles as Potent Bromodomain and Extra-Terminal Domain (BET) Family Bromodomain Inhibitors Le Wang, John K. Pratt, Todd Soltwedel, Journal of Medicinal Chemistry	2017	64
Imidazo[2,1-b]thiazoles: Multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases Steve Fidanze, Scott Erickson, Gary T. Wang, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineReceptor Tyrosine KinaseReceptor Tyrosine KinasesPharmacology	2010	56
Synthesis and Biological Evaluation of (−)-Laulimalide Analogues Paul A. Wender, Sayee G. Hegde, Robert D. Hubbard, Organic Letters	2003	48
Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors Alex G. Waterson, Kimberly G. Petrov, Keith R. Hornberger, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryAniline HeadgroupsBiochemistryMedicine	2009	39

Page 1